Healthcare Industry Contraceptives Market Share and Size, 2024 | Page 2

Your Catalyst To a Lucrative Business
The availability of an extensive product line within the industry provides expansion prospects. The
contraceptives market is fragmented by products, applications, and geographies. Vaginal implants, sponges,
diaphragms, condoms, femdoms, subdermal implants, IUDs, and others are the products. In a research
conducted lately, subdermal implants have been found to possess vast potential for family planning. IUDs
accounted for one of the biggest shares in 2014 due to demand in Europe & Asia Pacific.
Gynecologists selecting IUDs for birth-control are expected to raise segment growth. Mirena, a hormonal IUD,
employed broadly across North America could enhance the regional sales of IUDs. There are three kinds of
contraceptive drugs. These are pills, injectables, and topical. Pills led the industry in 2014 in view of their large
client-base and reproductive women’s unmet demands.
Applications comprise homes, clinics, hospitals, and others. Clinics occupied substantial shares and provide
services across all genders & ages. Hospitals are known for offering permanent contraception. Homes produced
the maximum sales. On the basis of regions, the contraceptives market is divided into North America, Europe,
Asia Pacific, and rest of the world.
North America captured the largest shares in 2015. Its shares were attributed to high abortion rates & patient
awareness. Europe observes huge penetration of subdermal implants and IUDs. Rest of the world will expand
rapidly due to its vast unexplored prospects. An unmet contraceptive demand of approximately 215 million
people globally is likely to propel this region. Asia Pacific impacts the worldwide Contraceptives market in
reference to demographics & low awareness.
The Female Health Company, Church & Dwight, Cooper Surgical, and Actavis plc accounted for majority of the
global revenues. Rivalry in the worldwide industry will stay relatively high till 2024. Industry manufacturers face
continuous pressure to introduce technologically-innovative and novel products. The industry has been a
witness to advancements in terms of self-administrative contraceptives. New product developments in
response to the demand for innovative contraception are one of the basic strategies employed by players to
occupy higher shares.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-
category/pharmaceuticals-industry
Follow Us: